Mottiwala Aziz, Chief Commercial Officer at Tarsus Pharmaceuticals ($TARS), sold about $1.27 million in company shares across four open market transactions over the past year, with the latest on June 9, 2025. These sales rank 4,382nd among 11,678 insiders in our database, below the average of $8.6 million per seller and 6.4 transactions. Aziz made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 4286 | $69.42 | 70,250.0000 | 42,607,717 | 5.75% | 0.01% |
| March 19, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 4440 | $67.00 | 61,480.0000 | 42,607,717 | 6.74% | 0.01% |
| March 18, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 4330 | $68.71 | 65,920.0000 | 42,607,717 | 6.16% | 0.01% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | M | Restricted Stock Units | 8020 | $0.00 | 16,040.0000 | 42,607,717 | 33.33% | 0.02% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | M | Restricted Stock Units | 5524 | $0.00 | 16,574.0000 | 42,607,717 | 25.00% | 0.01% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | M | Common Stock | 26482 | $0.00 | 74,536.0000 | 42,607,717 | 55.11% | 0.06% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | M | Restricted Stock Units | 4790 | $0.00 | 0.0000 | 42,607,717 | 100.00% | 0.01% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | M | Restricted Stock Units | 8148 | $0.00 | 8,148.0000 | 42,607,717 | 50.00% | 0.02% |
| March 5, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | A | Restricted Stock Units | 19306 | $0.00 | 19,306.0000 | 42,607,717 | 9999.99% | 0.05% |
| March 5, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | A | Stock Option (right to buy) | 30724 | $0.00 | 30,724.0000 | 42,607,717 | 9999.99% | 0.07% |
| June 9, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 17500 | $43.76 | 47,557.0000 | 37,604,538 | 26.90% | 0.05% |
| March 18, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 3643 | $46.29 | 71,979.0000 | 37,604,538 | 4.82% | 0.01% |
| March 19, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 3557 | $47.40 | 68,422.0000 | 37,604,538 | 4.94% | 0.01% |
| March 20, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 3365 | $50.11 | 65,057.0000 | 37,604,538 | 4.92% | 0.01% |
| March 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | M | Restricted Stock Units | 4790 | $0.00 | 4,790.0000 | 37,604,538 | 50.00% | 0.01% |
| March 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | M | Restricted Stock Units | 8148 | $0.00 | 16,296.0000 | 37,604,538 | 33.33% | 0.02% |
| March 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | M | Restricted Stock Units | 8019 | $0.00 | 24,060.0000 | 37,604,538 | 25.00% | 0.02% |
| March 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | M | Common Stock | 20957 | $0.00 | 75,622.0000 | 37,604,538 | 38.34% | 0.06% |
| March 5, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | A | Stock Option (right to buy) | 33691 | $0.00 | 33,691.0000 | 37,604,538 | 9999.99% | 0.09% |
| March 5, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | A | Restricted Stock Units | 22098 | $0.00 | 22,098.0000 | 37,604,538 | 9999.99% | 0.06% |
| March 15, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | M | Common Stock | 12938 | $0.00 | 58,841.0000 | 29,383,276 | 28.19% | 0.04% |
| March 15, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | M | Restricted Stock Units | 8148 | $0.00 | 24,444.0000 | 29,383,276 | 25.00% | 0.03% |
| March 18, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 4766 | $30.60 | 54,075.0000 | 29,383,276 | 8.10% | 0.02% |
| March 15, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | M | Restricted Stock Units | 4790 | $0.00 | 9,580.0000 | 29,383,276 | 33.33% | 0.02% |
| March 7, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | A | Stock Option (right to buy) | 47500 | $0.00 | 47,500.0000 | 29,383,276 | 9999.99% | 0.16% |
| March 7, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | A | Restricted Stock Units | 32079 | $0.00 | 32,079.0000 | 29,383,276 | 9999.99% | 0.11% |
| July 19, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 2400 | $20.05 | 45,806.0000 | 24,619,700 | 4.98% | 0.01% |
| June 8, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 100 | $20.00 | 48,086.0000 | 24,619,700 | 0.21% | 0.00% |
| June 7, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 2500 | $19.34 | 48,186.0000 | 24,619,700 | 4.93% | 0.01% |
| June 6, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 2143 | $18.61 | 50,686.0000 | 24,619,700 | 4.06% | 0.01% |
| March 23, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 372 | $12.15 | 52,829.0000 | 24,619,700 | 0.70% | 0.00% |
| March 21, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 349 | $12.89 | 53,558.0000 | 24,619,700 | 0.65% | 0.00% |
| March 22, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 357 | $12.64 | 53,201.0000 | 24,619,700 | 0.67% | 0.00% |
| March 17, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 339 | $13.28 | 54,265.0000 | 24,619,700 | 0.62% | 0.00% |
| March 20, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 358 | $12.61 | 53,907.0000 | 24,619,700 | 0.66% | 0.00% |
| March 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | M | Restricted Stock Units | 4790 | $0.00 | 14,370.0000 | 24,619,700 | 25.00% | 0.02% |
| March 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | M | Common Stock | 4790 | $0.00 | 54,940.0000 | 24,619,700 | 9.55% | 0.02% |
| March 16, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | S | Common Stock | 336 | $13.43 | 54,604.0000 | 24,619,700 | 0.61% | 0.00% |
| March 8, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | A | Stock Option (right to buy) | 48116 | $0.00 | 48,116.0000 | 24,619,700 | 9999.99% | 0.20% |
| March 8, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Mottiwala Aziz | Chief Commercial Officer | A | Restricted Stock Units | 32592 | $0.00 | 32,592.0000 | 24,619,700 | 9999.99% | 0.13% |